Beijing Government Views AutekBio Funding Test For Future Investment
This article was originally published in PharmAsia News
Executive Summary
What can $100 million in venture funds, partially funded by the Beijing government get you these days? For AutekBio, it gets the beginnings of China's largest biologics contract manufacturing facility, a buyout option, and more security than traditional VC funds
You may also be interested in...
Creative Funding Options For China; Investors Battle Perception of Home Court Advantage
The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns
Creative Funding Options For China; Investors Battle Perception of Home Court Advantage
The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns
China's Contract Manufacturing Growth Tied To Losses In The West
SHANGHAI - China's contract manufacturing market, the world's largest supplier of bulk drug materials, is expected to reach a value of roughly $2 billion in FY2010, according to consulting firm Frost & Sullivan